Buyout (LBO, MBO, MBI) • Life Science

Edgecap Partners Acquires Comac Medical

On June 9, 2023, family office Edgecap Partners acquired life science company Comac Medical

Acquisition Context
  • This is Edgecap Partners’ 1st transaction in the Life Science sector.
  • This is Edgecap Partners’ 1st transaction in Bulgaria.

Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free


M&A Deal Summary

Date June 9, 2023
Target Comac Medical
Sector Life Science
Buyer(s) Edgecap Partners
Deal Type Buyout (LBO, MBO, MBI)

Target Company

Comac Medical

Sofia, Bulgaria
Comac Medical is a full-service clinical research organization (CRO) in South-Eastern Europe, present in more than 30 countries, providing a comprehensive range of early to late-phase drug development services to the global pharmaceutical and biotech industries across a variety of therapeutic areas with a differentiated expertise and track record for indications within oncology, dermatology, gastroenterology, and respiratory diseases. The Company has a global customer base consisting of emerging biotech and established pharmaceutical companies, offering full outsourced clinical trial support across the entire clinical development timeline. Comac Medical was formed in 1997 and is based in Sofia, Bulgaria.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

DESCRIPTION

Edgecap Partners is a family-backed mid-market private equity and growth capital firm targeting investments into companies across Europe. The Firm looks to commit €10 to €100 million per investment. Edgecap Partners was formed in 2021 and is based in London.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Buyout (LBO, MBO, MBI) 1 of 1
Country: Bulgaria 1 of 1
Year: 2023 1 of 1